SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-21-000035
Filing Date
2021-08-03
Accepted
2021-08-03 10:10:45
Documents
14
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hska-20210803.htm   iXBRL 8-K 42233
2 EX-99.1 ex99-1earningsreleaseq22021.htm EX-99.1 238310
6 LOGO heskalogoa05a.jpg GRAPHIC 45126
  Complete submission text file 0001038133-21-000035.txt   507925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20210803.xsd EX-101.SCH 1894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20210803_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20210803_pre.xml EX-101.PRE 12506
7 EXTRACTED XBRL INSTANCE DOCUMENT hska-20210803_htm.xml XML 19064
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 211138332
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences